23 February 2017
News and Views
Links and Services
The most recent issue of Alimentary Pharmacology & Therapeutics evaluates the efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C.
Limited data are available on the efficacy and safety of antiviral therapy in geriatric patients
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors